Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.
about
The Regenerative Role of the Fetal and Adult Stem Cell SecretomeCell based therapies for ischemic stroke: from basic science to bedsideOver-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardiumAugmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathyAblation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6.New concepts on the immune modulation mediated by mesenchymal stem cells.Lipopolysaccharide pretreatment protects against ischemia/reperfusion injury via increase of HSP70 and inhibition of NF-κB.The combination of red palm oil and rooibos show anti-inflammatory effects in rats.Lipopolysaccharide pretreatment inhibits LPS-induced human umbilical cord mesenchymal stem cell apoptosis via upregulating the expression of cellular FLICE-inhibitory protein.TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular diseaseLPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b.Lipopolysaccharide treatment induces genome-wide pre-mRNA splicing pattern changes in mouse bone marrow stromal stem cells.The cardioprotection induced by lipopolysaccharide involves phosphoinositide 3-kinase/Akt and high mobility group box 1 pathwaysA critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance.Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament HealingRepair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potentialToll-like receptors: new players in myocardial ischemia/reperfusion injury.Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.Preconditioning strategy in stem cell transplantation therapy.Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulationPretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.Pretreatment of Mesenchymal Stem Cells With Leishmania major Soluble Antigens Induce Anti-Inflammatory Properties in Mouse Peritoneal Macrophages.Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardiumToll-like receptors as modulators of mesenchymal stem cells.Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway.Adjudin-preconditioned neural stem cells enhance neuroprotection after ischemia reperfusion in mice.Wisp2 disruption represses Cxcr4 expression and inhibits BMSCs homing to injured liver.Sub-physiological oxygen levels optimal for growth and survival of human atrial cardiac stem cells.Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs).Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.Bone marrow mesenchymal stem cells protect alveolar macrophages from lipopolysaccharide-induced apoptosis partially by inhibiting the Wnt/β-catenin pathway.Tenascin‑C promotes the migration of bone marrow stem cells via toll‑like receptor 4‑mediated signaling pathways: MAPK, AKT and Wnt.Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.
P2860
Q27004398-189BB29B-1827-4143-8153-7E250EBC1C5AQ27025754-453DE756-C73D-4A9A-A65A-F74221A4F6BCQ28576241-AF3418D9-5BEE-4A0D-A383-2CC88B41B98CQ33694021-A9F621C9-AC44-4912-A3F4-0FFC622A648CQ33708002-9701D0BB-DDE8-42FD-84B9-7D1599F036A9Q33969148-8A57366D-AA50-4A61-89E9-7C0545E0943DQ34513159-EB613BD4-DC1C-4547-A012-8C5002D93CBDQ34797253-83DD2CB7-3571-4090-BEEC-0EEAE0437823Q34979049-72273E71-70DC-42DC-8F66-8AB482E13D40Q35728777-1BCA79A0-E060-497D-86E3-0356154BA3E5Q35803790-A2D3277C-2A32-427B-B3AE-9C64E2DF6FC3Q35804026-2A370E21-41E5-4D8E-97F9-F173FCFBCBF0Q36073902-A1F2C67E-AA89-49BF-A4EF-8D0360E58C31Q36111569-A81E4670-3812-4210-8ECB-A67EEC9FF09CQ36681594-B7EB2184-26E9-4F15-90A6-50D847A687ABQ36907139-A11C6FE5-3C99-48BC-B487-3D6CC034FED5Q37143047-B1039636-A270-4DD6-9822-9F6DBBB54081Q37294044-BF8B5B27-8F03-4F1B-8C3D-D4032AF9653FQ37772403-AB98EC91-BF90-4586-858C-867EEA315FCCQ37810952-E8523ACF-82F6-4520-82BF-1084375189CEQ38005087-1914C5E4-1DA3-426D-9708-F2175F9FB59BQ38126494-93F93A33-9A4D-4976-8B60-8A6094726637Q39017865-36E4BBA2-B39B-402F-964B-A03854791B55Q39115395-8ABDD947-E335-42BB-968E-ADF6C98E9A10Q39242312-55FC2755-CD22-4172-AC28-29B530B81DA6Q40340777-AA9541F1-A668-4359-8837-26087A1F96BCQ41212597-F1A4B0F6-6327-4463-B69B-D0459E6264B8Q42041083-1C43D8C3-7479-46A5-A574-EAF2513FAFCCQ42221839-4C5586C5-7092-4437-B042-D59979A50F06Q44298061-AE4F1D5C-C282-461C-9C30-13F6EAFA5DBDQ44372625-3014DC5B-5AB6-4A7E-818E-C277760EBCB9Q44562660-56BCBADB-0974-4A7C-A5CA-3B106DAFA2C5Q47101762-1AA599BB-7D59-4787-AFBD-063A6160DB95Q47926132-E1F1E28A-B0D7-4230-A610-351413147A3CQ49178540-503BE6C3-8CD3-4967-B3B7-2AD4720607CDQ50462523-6EF9ED12-9C8F-46DA-8C9C-1F08145DCF5AQ51697178-CFA4460E-A655-4726-985F-D0F8909853FAQ52605260-6667C29E-4C88-4AD3-8F69-6834C66AEF3AQ55065461-E1D5FFC5-2BB7-4DED-9386-615BD54103B2
P2860
Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@en
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@nl
type
label
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@en
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@nl
prefLabel
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@en
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@nl
P2093
P2860
P356
P1476
Lipopolysaccharide preconditio ...... f acute myocardial infarction.
@en
P2093
Fumin Zhang
Guohui Zhang
Jianmei Chen
Liansheng Wang
Yongwei Yao
Zhaojun Wang
P2860
P2888
P356
10.1186/1423-0127-16-74
P577
2009-08-20T00:00:00Z
P5875
P6179
1035960955